CD274 and cancer: Depending on cancer entity, predictive biomarkers, such as the PD-(L)1 expression and related scores are routinely used as a potential decision tool and as predictive biomarkers in clinical practice in certain types of cancer (3, 4), yet their predictive ability is nevertheless inaccurate in most treatment settings.